Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia

Published:2019-11-04 Issue:3 Volume:61 Page:614-622
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Derman Benjamin A.¹^ORCID,Streck Mitchell²,Wynne Joseph¹,Christ Trevor N.³⁴,Curran Emily¹,Stock Wendy¹,Knoebel Randall W.³

Affiliation:

1. Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;

2. Simon Cancer Center, Indiana University Health, Indianapolis, IN, USA;

3. Department of Pharmacy, University of Chicago, Chicago, IL, USA;

4. Rush University Medical Center, Chicago, IL, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1680839

Reference34 articles.

1. Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia

2. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: Systematic review and meta-analysis

3. Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia

4. Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia

5. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia;Blood Reviews;2024-07

2. Retrospective review of the toxicities and change in dosing patterns for pegaspargase in patients with acute lymphoblastic leukemia/lymphoma and T-cell lymphoma;Journal of Oncology Pharmacy Practice;2024-04-13

3. Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase;Hematology;2024-03-25

4. Asparaginase dosing for obese patients with acute lymphoblastic leukemia and factors that contribute to outcomes;Best Practice & Research Clinical Haematology;2023-12

5. SOHO State of the Art Updates and Next Questions | Approach to Older Adults With Phildadelphia-Chromosome Negative Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2023-11